In vitro and in vivo inhibition of human Fanconi anemia head and neck squamous carcinoma by a phytonutrient combination

16Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

Head and neck squamous cell carcinoma (HNSCC) and acute myeloid leukemia are the major causes of mortality and morbidity in Fanconi anemia (FA) patients. The objective of this study was to investigate the antineoplastic activity of PB, an antineoplastic nutrient mixture (containing quercetin, curcumin, green tea, cruciferex and resveratrol) on human FA HNSCC in vitro and in vivo. Human FA HNSCC cell line OHSU-974 (Fanconi Anemia Research Fund) was cultured in RPMI medium supplemented with 20% FBS and antibiotics. At near confluence, cells were treated in triplicate with different concentrations of PB: 0, 10, 25, 50, 75 and 100 μg/ml. Cells were also treated with PMA to induce MMP-9 activity. Cell proliferation was detected by MTT assay, secretion of MMPs by gelatinase zymography, invasion through Matrigel, migration by scratch test and morphology by hematoxylin and eosin (H&E) staining. In vivo, athymic male nude mice (n=12) were inoculated with 3×106 OHSU-974 cells subcutaneously and randomly divided into two groups: group A was fed a regular diet and group B a regular diet supplemented with 1% PB. Four weeks later, the mice were sacrificed and their tumors were excised, weighed and processed for histology. NM inhibited the growth of OHSU-974 tumor by 67.6% (p<0.0001) and tumor burden by 63.6% (p<0.0001). PB demonstrated dose-dependent inhibition of cell proliferation, with 27% (p=0.0003) and 48% (p=0.0004) toxicity at 75 and 100 μg/ml, respectively. Zymography revealed MMP-2 and PMA-induced MMP-9 secretion. PB suppressed secretion of both MMPs in a dose-dependent manner, with total block of both at 50 μg/ml. PB inhibited cell migration (by scratch test) and OHSU-974 invasion through Matrigel in a dose-dependent fashion with total block at 50 μg/ml. H&E staining showed no morphological changes below 50 μg/ml. The results suggest that PB has potential therapeutic use in the treatment of human FA HNSCC.

References Powered by Scopus

Curcumin and cancer: An "old-age" disease with an "age-old" solution

1047Citations
N/AReaders
Get full text

Tea polyphenols: Prevention of cancer and optimizing health

840Citations
N/AReaders
Get full text

Western diet and western diseases: Some hormonal and biochemical mechanisms and associations

715Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Potential adverse effects of resveratrol: A literature review

452Citations
N/AReaders
Get full text

Anticancer efficacy of polyphenols and their combinations

428Citations
N/AReaders
Get full text

Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives

99Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Roomi, M. W., Kalinovsky, T., Roomi, N. W., Niedzwiecki, A., & Rath, M. (2015). In vitro and in vivo inhibition of human Fanconi anemia head and neck squamous carcinoma by a phytonutrient combination. International Journal of Oncology, 46(5), 2261–2266. https://doi.org/10.3892/ijo.2015.2895

Readers over time

‘16‘17‘18‘19‘20‘21‘22‘23‘24‘25036912

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 7

50%

Professor / Associate Prof. 3

21%

Researcher 3

21%

Lecturer / Post doc 1

7%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 6

30%

Nursing and Health Professions 6

30%

Biochemistry, Genetics and Molecular Bi... 5

25%

Medicine and Dentistry 3

15%

Save time finding and organizing research with Mendeley

Sign up for free
0